Immunome Overview
Immunome Target Price
Analysts' 12-month price predictions for IMNM.
Get informed when a big investor buys or sells
+ FollowShare Price
$19.75
Average Target Price
$35.33
78.9% upside
78.9% upside3 analysts in the last 4 months
High: $37 | Low: $33
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-28 | Truist FinancialSupawat Thongthip | $37 | 87.3% upside |  |
| 2026-05-28 | BarclaysLukas Shumway | $36 | 82.3% upside | |
| 2026-05-15 | Leerink PartnersAndrew Berens | $33 | 67.1% upside | |
| 2026-02-12 | H.C. Wainwright | $40 | 102.5% upside | |
| 2025-12-16 | Lake Street | $32 | 62% upside | |
| 2025-12-16 | Evercore ISI | $40 | 102.5% upside | |
| 2025-12-15 | Leerink Partners | $40 | 102.5% upside | |
| 2025-12-01 | Truist FinancialKarina Rabayeva | $36 | 82.3% upside | |
| 2025-11-17 | Stephens | $33 | 67.1% upside | |
| 2025-09-05 | Craig-Hallum | $26 | 31.6% upside | |
| 2025-08-22 | Evercore ISI | $18 |  8.9% downside | |
| 2024-08-13 | Piper SandlerBiren Amin | $23 | 16.5% upside | |
| 2024-04-15 | GuggenheimMichael Schmidt | $35 | 77.2% upside | |
| 2024-04-01 | WedbushDavid Nierengarten | $33 | 67.1% upside | |